LOXL 2‐mediated chromatin compaction is required to maintain the oncogenic properties of triple‐negative breast cancer cells
Oxidation of histone H3 at lysine 4 (H3K4ox) is catalyzed by lysyl oxidase homolog 2 (LOXL2). This histone modification is enriched in heterochromatin in triple‐negative breast cancer (TNBC) cells and has been linked to the maintenance of compacted chromatin. However, the molecular mechanism underly...
Gespeichert in:
Veröffentlicht in: | The FEBS journal 2024-06, Vol.291 (11), p.2423-2448 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2448 |
---|---|
container_issue | 11 |
container_start_page | 2423 |
container_title | The FEBS journal |
container_volume | 291 |
creator | Serra‐Bardenys, Gemma Blanco, Enrique Escudero‐Iriarte, Carmen Serra‐Camprubí, Queralt Querol, Jessica Pascual‐Reguant, Laura Morancho, Beatriz Escorihuela, Marta Tissera, Natalia Soledad Sabé, Anna Martín, Luna Segura‐Bayona, Sandra Verde, Gaetano Aiese Cigliano, Riccardo Millanes‐Romero, Alba Jerónimo, Celia Cebrià‐Costa, Joan Pau Nuciforo, Paolo Simonetti, Sara Viaplana, Cristina Dienstmann, Rodrigo Oliveira, Mafalda Peg, Vicente Stracker, Travis H. Arribas, Joaquín Canals, Francesc Villanueva, Josep Di Croce, Luciano García de Herreros, Antonio Tian, Tian V. Peiró, Sandra |
description | Oxidation of histone H3 at lysine 4 (H3K4ox) is catalyzed by lysyl oxidase homolog 2 (LOXL2). This histone modification is enriched in heterochromatin in triple‐negative breast cancer (TNBC) cells and has been linked to the maintenance of compacted chromatin. However, the molecular mechanism underlying this maintenance is still unknown. Here, we show that LOXL2 interacts with RuvB‐Like 1 (RUVBL1), RuvB‐Like 2 (RUVBL2), Actin‐like protein 6A (ACTL6A), and DNA methyltransferase 1associated protein 1 (DMAP1), a complex involved in the incorporation of the histone variant H2A.Z. Our experiments indicate that this interaction and the active form of RUVBL2 are required to maintain LOXL2‐dependent chromatin compaction. Genome‐wide experiments showed that H2A.Z, RUVBL2, and H3K4ox colocalize in heterochromatin regions. In the absence of LOXL2 or RUVBL2, global levels of the heterochromatin histone mark H3K9me3 were strongly reduced, and the ATAC‐seq signal in the H3K9me3 regions was increased. Finally, we observed that the interplay between these series of events is required to maintain H3K4ox‐enriched heterochromatin regions, which in turn is key for maintaining the oncogenic properties of the TNBC cell line tested (MDA‐MB‐231). |
doi_str_mv | 10.1111/febs.17112 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1111_febs_17112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1111_febs_17112</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1111_febs_171123</originalsourceid><addsrcrecordid>eNqVj81OAkEQhCcGEhG4-AR9NgF3lkXkbDQeSLh44DYZhl5os_Nj92jijUfwGX0SB2O8U0ml6lCp5FPqWldTXXTb4lameqF1faEGetHUk-Zuft_7783mUl2JvFbVbN4slwN1XK03K6i_j18ed2Qz7sAdOHqbKYCLPlmXKQYgAca3d-IyyBG8pZCLIR8QYnBxj4EcJI4JORMKxBYyU-qwXAfcl78PhC2jlQzOBocMDrtORqrf2k5w_JdDdfP0-PLwPHEcRRhbk5i85U-jK3NiNCdG88s4O2v8A6CHXag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>LOXL 2‐mediated chromatin compaction is required to maintain the oncogenic properties of triple‐negative breast cancer cells</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Serra‐Bardenys, Gemma ; Blanco, Enrique ; Escudero‐Iriarte, Carmen ; Serra‐Camprubí, Queralt ; Querol, Jessica ; Pascual‐Reguant, Laura ; Morancho, Beatriz ; Escorihuela, Marta ; Tissera, Natalia Soledad ; Sabé, Anna ; Martín, Luna ; Segura‐Bayona, Sandra ; Verde, Gaetano ; Aiese Cigliano, Riccardo ; Millanes‐Romero, Alba ; Jerónimo, Celia ; Cebrià‐Costa, Joan Pau ; Nuciforo, Paolo ; Simonetti, Sara ; Viaplana, Cristina ; Dienstmann, Rodrigo ; Oliveira, Mafalda ; Peg, Vicente ; Stracker, Travis H. ; Arribas, Joaquín ; Canals, Francesc ; Villanueva, Josep ; Di Croce, Luciano ; García de Herreros, Antonio ; Tian, Tian V. ; Peiró, Sandra</creator><creatorcontrib>Serra‐Bardenys, Gemma ; Blanco, Enrique ; Escudero‐Iriarte, Carmen ; Serra‐Camprubí, Queralt ; Querol, Jessica ; Pascual‐Reguant, Laura ; Morancho, Beatriz ; Escorihuela, Marta ; Tissera, Natalia Soledad ; Sabé, Anna ; Martín, Luna ; Segura‐Bayona, Sandra ; Verde, Gaetano ; Aiese Cigliano, Riccardo ; Millanes‐Romero, Alba ; Jerónimo, Celia ; Cebrià‐Costa, Joan Pau ; Nuciforo, Paolo ; Simonetti, Sara ; Viaplana, Cristina ; Dienstmann, Rodrigo ; Oliveira, Mafalda ; Peg, Vicente ; Stracker, Travis H. ; Arribas, Joaquín ; Canals, Francesc ; Villanueva, Josep ; Di Croce, Luciano ; García de Herreros, Antonio ; Tian, Tian V. ; Peiró, Sandra</creatorcontrib><description>Oxidation of histone H3 at lysine 4 (H3K4ox) is catalyzed by lysyl oxidase homolog 2 (LOXL2). This histone modification is enriched in heterochromatin in triple‐negative breast cancer (TNBC) cells and has been linked to the maintenance of compacted chromatin. However, the molecular mechanism underlying this maintenance is still unknown. Here, we show that LOXL2 interacts with RuvB‐Like 1 (RUVBL1), RuvB‐Like 2 (RUVBL2), Actin‐like protein 6A (ACTL6A), and DNA methyltransferase 1associated protein 1 (DMAP1), a complex involved in the incorporation of the histone variant H2A.Z. Our experiments indicate that this interaction and the active form of RUVBL2 are required to maintain LOXL2‐dependent chromatin compaction. Genome‐wide experiments showed that H2A.Z, RUVBL2, and H3K4ox colocalize in heterochromatin regions. In the absence of LOXL2 or RUVBL2, global levels of the heterochromatin histone mark H3K9me3 were strongly reduced, and the ATAC‐seq signal in the H3K9me3 regions was increased. Finally, we observed that the interplay between these series of events is required to maintain H3K4ox‐enriched heterochromatin regions, which in turn is key for maintaining the oncogenic properties of the TNBC cell line tested (MDA‐MB‐231).</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.17112</identifier><language>eng</language><ispartof>The FEBS journal, 2024-06, Vol.291 (11), p.2423-2448</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_1111_febs_171123</cites><orcidid>0000-0001-5270-0808 ; 0000-0003-1396-9470 ; 0000-0001-9519-3877 ; 0009-0006-8911-6684 ; 0000-0002-9906-0980</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Serra‐Bardenys, Gemma</creatorcontrib><creatorcontrib>Blanco, Enrique</creatorcontrib><creatorcontrib>Escudero‐Iriarte, Carmen</creatorcontrib><creatorcontrib>Serra‐Camprubí, Queralt</creatorcontrib><creatorcontrib>Querol, Jessica</creatorcontrib><creatorcontrib>Pascual‐Reguant, Laura</creatorcontrib><creatorcontrib>Morancho, Beatriz</creatorcontrib><creatorcontrib>Escorihuela, Marta</creatorcontrib><creatorcontrib>Tissera, Natalia Soledad</creatorcontrib><creatorcontrib>Sabé, Anna</creatorcontrib><creatorcontrib>Martín, Luna</creatorcontrib><creatorcontrib>Segura‐Bayona, Sandra</creatorcontrib><creatorcontrib>Verde, Gaetano</creatorcontrib><creatorcontrib>Aiese Cigliano, Riccardo</creatorcontrib><creatorcontrib>Millanes‐Romero, Alba</creatorcontrib><creatorcontrib>Jerónimo, Celia</creatorcontrib><creatorcontrib>Cebrià‐Costa, Joan Pau</creatorcontrib><creatorcontrib>Nuciforo, Paolo</creatorcontrib><creatorcontrib>Simonetti, Sara</creatorcontrib><creatorcontrib>Viaplana, Cristina</creatorcontrib><creatorcontrib>Dienstmann, Rodrigo</creatorcontrib><creatorcontrib>Oliveira, Mafalda</creatorcontrib><creatorcontrib>Peg, Vicente</creatorcontrib><creatorcontrib>Stracker, Travis H.</creatorcontrib><creatorcontrib>Arribas, Joaquín</creatorcontrib><creatorcontrib>Canals, Francesc</creatorcontrib><creatorcontrib>Villanueva, Josep</creatorcontrib><creatorcontrib>Di Croce, Luciano</creatorcontrib><creatorcontrib>García de Herreros, Antonio</creatorcontrib><creatorcontrib>Tian, Tian V.</creatorcontrib><creatorcontrib>Peiró, Sandra</creatorcontrib><title>LOXL 2‐mediated chromatin compaction is required to maintain the oncogenic properties of triple‐negative breast cancer cells</title><title>The FEBS journal</title><description>Oxidation of histone H3 at lysine 4 (H3K4ox) is catalyzed by lysyl oxidase homolog 2 (LOXL2). This histone modification is enriched in heterochromatin in triple‐negative breast cancer (TNBC) cells and has been linked to the maintenance of compacted chromatin. However, the molecular mechanism underlying this maintenance is still unknown. Here, we show that LOXL2 interacts with RuvB‐Like 1 (RUVBL1), RuvB‐Like 2 (RUVBL2), Actin‐like protein 6A (ACTL6A), and DNA methyltransferase 1associated protein 1 (DMAP1), a complex involved in the incorporation of the histone variant H2A.Z. Our experiments indicate that this interaction and the active form of RUVBL2 are required to maintain LOXL2‐dependent chromatin compaction. Genome‐wide experiments showed that H2A.Z, RUVBL2, and H3K4ox colocalize in heterochromatin regions. In the absence of LOXL2 or RUVBL2, global levels of the heterochromatin histone mark H3K9me3 were strongly reduced, and the ATAC‐seq signal in the H3K9me3 regions was increased. Finally, we observed that the interplay between these series of events is required to maintain H3K4ox‐enriched heterochromatin regions, which in turn is key for maintaining the oncogenic properties of the TNBC cell line tested (MDA‐MB‐231).</description><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVj81OAkEQhCcGEhG4-AR9NgF3lkXkbDQeSLh44DYZhl5os_Nj92jijUfwGX0SB2O8U0ml6lCp5FPqWldTXXTb4lameqF1faEGetHUk-Zuft_7783mUl2JvFbVbN4slwN1XK03K6i_j18ed2Qz7sAdOHqbKYCLPlmXKQYgAca3d-IyyBG8pZCLIR8QYnBxj4EcJI4JORMKxBYyU-qwXAfcl78PhC2jlQzOBocMDrtORqrf2k5w_JdDdfP0-PLwPHEcRRhbk5i85U-jK3NiNCdG88s4O2v8A6CHXag</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Serra‐Bardenys, Gemma</creator><creator>Blanco, Enrique</creator><creator>Escudero‐Iriarte, Carmen</creator><creator>Serra‐Camprubí, Queralt</creator><creator>Querol, Jessica</creator><creator>Pascual‐Reguant, Laura</creator><creator>Morancho, Beatriz</creator><creator>Escorihuela, Marta</creator><creator>Tissera, Natalia Soledad</creator><creator>Sabé, Anna</creator><creator>Martín, Luna</creator><creator>Segura‐Bayona, Sandra</creator><creator>Verde, Gaetano</creator><creator>Aiese Cigliano, Riccardo</creator><creator>Millanes‐Romero, Alba</creator><creator>Jerónimo, Celia</creator><creator>Cebrià‐Costa, Joan Pau</creator><creator>Nuciforo, Paolo</creator><creator>Simonetti, Sara</creator><creator>Viaplana, Cristina</creator><creator>Dienstmann, Rodrigo</creator><creator>Oliveira, Mafalda</creator><creator>Peg, Vicente</creator><creator>Stracker, Travis H.</creator><creator>Arribas, Joaquín</creator><creator>Canals, Francesc</creator><creator>Villanueva, Josep</creator><creator>Di Croce, Luciano</creator><creator>García de Herreros, Antonio</creator><creator>Tian, Tian V.</creator><creator>Peiró, Sandra</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-5270-0808</orcidid><orcidid>https://orcid.org/0000-0003-1396-9470</orcidid><orcidid>https://orcid.org/0000-0001-9519-3877</orcidid><orcidid>https://orcid.org/0009-0006-8911-6684</orcidid><orcidid>https://orcid.org/0000-0002-9906-0980</orcidid></search><sort><creationdate>202406</creationdate><title>LOXL 2‐mediated chromatin compaction is required to maintain the oncogenic properties of triple‐negative breast cancer cells</title><author>Serra‐Bardenys, Gemma ; Blanco, Enrique ; Escudero‐Iriarte, Carmen ; Serra‐Camprubí, Queralt ; Querol, Jessica ; Pascual‐Reguant, Laura ; Morancho, Beatriz ; Escorihuela, Marta ; Tissera, Natalia Soledad ; Sabé, Anna ; Martín, Luna ; Segura‐Bayona, Sandra ; Verde, Gaetano ; Aiese Cigliano, Riccardo ; Millanes‐Romero, Alba ; Jerónimo, Celia ; Cebrià‐Costa, Joan Pau ; Nuciforo, Paolo ; Simonetti, Sara ; Viaplana, Cristina ; Dienstmann, Rodrigo ; Oliveira, Mafalda ; Peg, Vicente ; Stracker, Travis H. ; Arribas, Joaquín ; Canals, Francesc ; Villanueva, Josep ; Di Croce, Luciano ; García de Herreros, Antonio ; Tian, Tian V. ; Peiró, Sandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1111_febs_171123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serra‐Bardenys, Gemma</creatorcontrib><creatorcontrib>Blanco, Enrique</creatorcontrib><creatorcontrib>Escudero‐Iriarte, Carmen</creatorcontrib><creatorcontrib>Serra‐Camprubí, Queralt</creatorcontrib><creatorcontrib>Querol, Jessica</creatorcontrib><creatorcontrib>Pascual‐Reguant, Laura</creatorcontrib><creatorcontrib>Morancho, Beatriz</creatorcontrib><creatorcontrib>Escorihuela, Marta</creatorcontrib><creatorcontrib>Tissera, Natalia Soledad</creatorcontrib><creatorcontrib>Sabé, Anna</creatorcontrib><creatorcontrib>Martín, Luna</creatorcontrib><creatorcontrib>Segura‐Bayona, Sandra</creatorcontrib><creatorcontrib>Verde, Gaetano</creatorcontrib><creatorcontrib>Aiese Cigliano, Riccardo</creatorcontrib><creatorcontrib>Millanes‐Romero, Alba</creatorcontrib><creatorcontrib>Jerónimo, Celia</creatorcontrib><creatorcontrib>Cebrià‐Costa, Joan Pau</creatorcontrib><creatorcontrib>Nuciforo, Paolo</creatorcontrib><creatorcontrib>Simonetti, Sara</creatorcontrib><creatorcontrib>Viaplana, Cristina</creatorcontrib><creatorcontrib>Dienstmann, Rodrigo</creatorcontrib><creatorcontrib>Oliveira, Mafalda</creatorcontrib><creatorcontrib>Peg, Vicente</creatorcontrib><creatorcontrib>Stracker, Travis H.</creatorcontrib><creatorcontrib>Arribas, Joaquín</creatorcontrib><creatorcontrib>Canals, Francesc</creatorcontrib><creatorcontrib>Villanueva, Josep</creatorcontrib><creatorcontrib>Di Croce, Luciano</creatorcontrib><creatorcontrib>García de Herreros, Antonio</creatorcontrib><creatorcontrib>Tian, Tian V.</creatorcontrib><creatorcontrib>Peiró, Sandra</creatorcontrib><collection>CrossRef</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serra‐Bardenys, Gemma</au><au>Blanco, Enrique</au><au>Escudero‐Iriarte, Carmen</au><au>Serra‐Camprubí, Queralt</au><au>Querol, Jessica</au><au>Pascual‐Reguant, Laura</au><au>Morancho, Beatriz</au><au>Escorihuela, Marta</au><au>Tissera, Natalia Soledad</au><au>Sabé, Anna</au><au>Martín, Luna</au><au>Segura‐Bayona, Sandra</au><au>Verde, Gaetano</au><au>Aiese Cigliano, Riccardo</au><au>Millanes‐Romero, Alba</au><au>Jerónimo, Celia</au><au>Cebrià‐Costa, Joan Pau</au><au>Nuciforo, Paolo</au><au>Simonetti, Sara</au><au>Viaplana, Cristina</au><au>Dienstmann, Rodrigo</au><au>Oliveira, Mafalda</au><au>Peg, Vicente</au><au>Stracker, Travis H.</au><au>Arribas, Joaquín</au><au>Canals, Francesc</au><au>Villanueva, Josep</au><au>Di Croce, Luciano</au><au>García de Herreros, Antonio</au><au>Tian, Tian V.</au><au>Peiró, Sandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LOXL 2‐mediated chromatin compaction is required to maintain the oncogenic properties of triple‐negative breast cancer cells</atitle><jtitle>The FEBS journal</jtitle><date>2024-06</date><risdate>2024</risdate><volume>291</volume><issue>11</issue><spage>2423</spage><epage>2448</epage><pages>2423-2448</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Oxidation of histone H3 at lysine 4 (H3K4ox) is catalyzed by lysyl oxidase homolog 2 (LOXL2). This histone modification is enriched in heterochromatin in triple‐negative breast cancer (TNBC) cells and has been linked to the maintenance of compacted chromatin. However, the molecular mechanism underlying this maintenance is still unknown. Here, we show that LOXL2 interacts with RuvB‐Like 1 (RUVBL1), RuvB‐Like 2 (RUVBL2), Actin‐like protein 6A (ACTL6A), and DNA methyltransferase 1associated protein 1 (DMAP1), a complex involved in the incorporation of the histone variant H2A.Z. Our experiments indicate that this interaction and the active form of RUVBL2 are required to maintain LOXL2‐dependent chromatin compaction. Genome‐wide experiments showed that H2A.Z, RUVBL2, and H3K4ox colocalize in heterochromatin regions. In the absence of LOXL2 or RUVBL2, global levels of the heterochromatin histone mark H3K9me3 were strongly reduced, and the ATAC‐seq signal in the H3K9me3 regions was increased. Finally, we observed that the interplay between these series of events is required to maintain H3K4ox‐enriched heterochromatin regions, which in turn is key for maintaining the oncogenic properties of the TNBC cell line tested (MDA‐MB‐231).</abstract><doi>10.1111/febs.17112</doi><orcidid>https://orcid.org/0000-0001-5270-0808</orcidid><orcidid>https://orcid.org/0000-0003-1396-9470</orcidid><orcidid>https://orcid.org/0000-0001-9519-3877</orcidid><orcidid>https://orcid.org/0009-0006-8911-6684</orcidid><orcidid>https://orcid.org/0000-0002-9906-0980</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-464X |
ispartof | The FEBS journal, 2024-06, Vol.291 (11), p.2423-2448 |
issn | 1742-464X 1742-4658 |
language | eng |
recordid | cdi_crossref_primary_10_1111_febs_17112 |
source | Wiley Online Library Journals Frontfile Complete |
title | LOXL 2‐mediated chromatin compaction is required to maintain the oncogenic properties of triple‐negative breast cancer cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A10%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LOXL%202%E2%80%90mediated%20chromatin%20compaction%20is%20required%20to%20maintain%20the%20oncogenic%20properties%20of%20triple%E2%80%90negative%20breast%20cancer%20cells&rft.jtitle=The%20FEBS%20journal&rft.au=Serra%E2%80%90Bardenys,%20Gemma&rft.date=2024-06&rft.volume=291&rft.issue=11&rft.spage=2423&rft.epage=2448&rft.pages=2423-2448&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.17112&rft_dat=%3Ccrossref%3E10_1111_febs_17112%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |